Clinical trial

An Observational Study to Learn More About Treatment Patterns and Factors Determining the Choice of Treatment in Canadian Men With Metastatic Hormone Sensitive Prostate Cancer in Routine Medical Care

NCT06874114

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2025-02-28

PhaseN/A

Study timeline

Study start (actual)2025-02-28Date precision: day

Registry last updated2026-10-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Hormone-sensitive Prostate Cancerunresolved

Interventions

Sponsors & collaborators

Bayerlead sponsor

Mapped research locations

TorontoOntario, Canada1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06874114 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.